Tito Fojo - Publications, H-index & Citations

Tito Fojo

columbia university irving medical center

83H指数

408论文数

3.4W被引数

收录论文 116

发表时间

Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives 莫替沙福肽、西米普利单抗、吉西他滨和纳布紫杉醇在转移性胰腺癌中的应用：一项含单细胞相关分析的单一队列2期研究

Nature Communications

IF15.7

2026-08-21

OAAI

Alexander G. Raufi; Edridge K. D’Souza; Michael S. May; Sarah Sedycias; Ilenia Pellicciotta; Samuel Pan; Shikun Wang; Carmine Palermo; Steven Sastra; Naomi Sender; Isabelle Ross; Li Li; Karan Luthria; Parin Shah; Somnath Tagore; Zachary H. Walsh; Andrew Turk; Bircan Sema; Alina Iuga; Sun Dajiang; Michael D. Kluger; Beth A. Schrope; Dane Brown; Tito Fojo; Juan-Manuel Schvartzman; Yoanna Pumpalova; Ryan H. Moy; Susan Bates; Linda Wu; Hanina Hibshoosh; Aik Choon Tan; Gary K. Schwartz; John A. Chabot; Kenneth P. Olive; Benjamin Izar; Gulam A. Manji

Crossover does not confound, it informs: 177lutetium-PSMA-617 as an example 交叉不混淆，而是提供信息：177Lu-PSMA-617为例

Nature Reviews Clinical Oncology

IF82.2

2026-07-16

PREAI

Martin W. Schoen; Tito Fojo; Johann de Bono

Conflicts of interest and interpretive authority in oncology 利益冲突与肿瘤学中的解释权

European Journal of Cancer

IF7.1

2026-05-28

OAAI

Saroj Niraula; Samuel X. Stevens; Tito Fojo; Ian F. Tannock

Letter to the Editor Regarding ‘Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer’致编辑：关于《在转移性去势敏感型前列腺癌中阿帕鲁他胺与恩扎鲁他胺的总生存期比较》

Advances in Therapy

IF4

2025-11-28

OAAI

Martin W. Schoen; Tito Fojo

Highlights of ASCO 2025 ASCO 2025亮点

The Oncologist

IF0

2025-11-11

OAAI

Brandon DaSilva, MD; Alfred I Neugut, MD, PhD; Tito Fojo, MD, PhD; Susan E Bates, MD

Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma HDAC与eIF4A联合抑制：一种新型表观遗传疗法用于治疗胰腺导管腺癌

Drug Resistance Updates

IF21.7

2025-10-04

PREAI

Maryam Safari; Luigi Scotto; Agnes Basseville; Thomas Litman; Haoran Xue; Lubov Petrukhin; Ping Zhou; Helen E. Remotti; Amy Ku; Diana V. Morales; Christopher Damoci; Mingzhao Zhu; Ravikanth Maddipati; Kenneth G. Hull; Robert W. Robey; Kenneth P. Olive; Tito Fojo; Daniel Romo; Susan E. Bates

From dimensions through dynamics to outcomes - lymph nodes and skin assessments predict CTCL outcomes 从维度到动力学再到结局——淋巴结和皮肤评估可预测CTCL结局

LEUKEMIA & LYMPHOMA

IF2.2

2025-09-01

PREAI

Kaminsky, Alexander; Fahmy, Lauren M.; Bilgrami, Zaid; Yang, Hye Ryung; Beylergil, Volkan; Zhou, Mengxi; Suhl, Sara; Bates, Susan E.; Fojo, Tito; Yang, Hao; Schwartz, Lawrence H.; Geskin, Larisa J.

Skimming the Median and the Problem of Exaggerated Survival Gains 扫描中位数和夸大生存获益的问题

JAMA ONCOLOGY

IF20.1

2025-05-22

PREAI

Fojo, Tito; Bates, Susan

Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecan 曲妥珠单抗德鲁替康治疗转移性乳腺癌患者中肿瘤生长速率与生存期的相关性

ONCOLOGIST

IF4.2

2025-05-11

OAAI

He, Philip; Gambhire, Dhiraj; Zhou, Haiming; Ma, Xiaoyang; Emura, Yoshihiro; Laadem, Abderrahmane; Leung, David; Bates, Susan; Fojo, Antonio Tito; Rixe, Olivier

Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses

EBIOMEDICINE

IF10.8

2024-09-01

OAAI

Leuva, Harshraj; Zhou, Mengxi; Jamaleddine, Nader; Meseha, Mina; Faiena, Izak; Park, Yeun-Hee Anna; McWilliams, Glen; Luhrs, Carol; Maxwell, Kara N.; Von Hoff, Daniel; Bates, Susan E.; Fojob, Tito

The statistical significance revolution

JNCI CANCER SPECTRUM

IF4.1

2024-04-29

OAAI

Neugut, Alfred, I; Fojo, Tito

Lessons from withdrawn accelerated approvals in oncology

NATURE CANCER

IF28.5

2024-01-30

PREAI

Mellgard, George S.; Fojo, Tito; Bates, Susan E.

Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement 生殖系SDHB致病变异患者的嗜铬细胞瘤和副神经节瘤的管理: 国际专家共识声明

nature reviews endocrinology

IF40

2023-12-14

PREAI

Taieb, David; Noelting, Svenja; Perrier, Nancy D.; Fassnacht, Martin; Carrasquillo, Jorge A.; Grossman, Ashley B.; Clifton-Bligh, Roderick; Wanna, George B.; Schwam, Zachary G.; Amar, Laurence; Bourdeau, Isabelle; Casey, Ruth T.; Crona, Joakim; Deal, Cheri L.; Del Rivero, Jaydira; Duh, Quan-Yang; Eisenhofer, Graeme; Fojo, Tito; Ghayee, Hans K.; Gimenez-Roqueplo, Anne-Paule; Gill, Antony J.; Hicks, Rodney; Imperiale, Alessio; Jha, Abhishek; Kerstens, Michiel N.; de Krijger, Ronald R.; Lacroix, Andre; Lazurova, Ivica; Lin, Frank I.; Lussey-Lepoutre, Charlotte; Maher, Eamonn R.; Mete, Ozgur; Naruse, Mitsuhide; Nilubol, Naris; Robledo, Mercedes; Sebag, Frederic; Shah, Nalini S.; Tanabe, Akiyo; Thompson, Geoffrey B.; Timmers, Henri J. L. M.; Widimsky, Jiri; Young, William J.; Meuter, Leah; Lenders, Jacques W. M.; Pacak, Karel

Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials

BREAST CANCER RESEARCH AND TREATMENT

IF3

2023-11-13

OAAI

Yeh, Celine; Zhou, Mengxi; Bapodra, Neil; Hershman, Dawn; Espinal, Edward; Moran, Marina; Rivero, Maria; Fojo, Antonio Tito; Bates, Susan E.

Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2023-10-16

OAAI

Lee, Eunhyeong; O'Keefe, Sophie; Leong, Alessandra; Park, Ha-Ram; Varadarajan, Janani; Chowdhury, Subrata; Hiner, Shannon; Kim, Sungsoo; Shiva, Anahita; Friedman, Richard A.; Remotti, Helen; Fojo, Tito; Yang, Hee Won; Thurston, Gavin; Kim, Minah

An imaging signature to predict outcome in metastatic colorectal cancer using routine computed tomography scans

EUROPEAN JOURNAL OF CANCER

IF7.1

2022-01-01

OAAI

Dercle, Laurent; Zhao, Binsheng; Gonen, Mithat; Moskowitz, Chaya S.; Connors, Dana E.; Yang, Hao; Lu, Lin; Reidy-Lagunes, Diane; Fojo, Tito; Karovic, Sanja; Maitland, Michael L.; Oxnard, Geoffrey R.; Schwartz, Lawrence H.

Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data

CANCER

IF5.1

2018-10-20

OAAI

Bauml, Joshua M.; Vinnakota, Ravi; Park, Yeun-Hee Anna; Bates, Susan E.; Fojo, Tito; Aggarwal, Charu; Di Stefano, Jessica; Knepley, Christina; Limaye, Sewanti; Mamtani, Ronac; Wisnivesky, Juan; Damjanov, Nevena; Langer, Corey J.; Cohen, Roger B.; Sigel, Keith

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2018-09-18

OAAI

Bauml, Joshua M.; Vinnakota, Ravi; Park, Yeun-Hee Anna; Bates, Susan E.; Fojo, Tito; Aggarwal, Charu; Limaye, Sewanti; Damjanov, Nevena; Di Stefano, Jessica; Ciunci, Christine; Genden, Eric M.; Wisnivesky, Juan P.; Ferrandino, Rocco; Mamtani, Ronac; Langer, Corey J.; Cohen, Roger B.; Sigel, Keith

Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy 通过周期性化疗持续减少转移性嗜铬细胞瘤/副神经节瘤的琥珀酸脱氢酶亚基B突变

CELLULAR AND MOLECULAR NEUROBIOLOGY

IF4.8

2018-04-05

OAAI

Jawed, Irfan; Velarde, Margarita; Darr, Roland; Wolf, Katherine I.; Adams, Karen; Venkatesan, Aradhana M.; Balasubramaniam, Sanjeeve; Poruchynsky, Marianne S.; Reynolds, James C.; Pacak, Karel; Fojo, Tito

The evidence framework for precision cancer medicine

NATURE REVIEWS CLINICAL ONCOLOGY

IF82.2

2017-12-19

112

PREAI

Moscow, Jeffrey A.; Fojo, Tito; Schilsky, Richard L.

研究方向